GeneDx Holdings Corp. (WGS) Misses Q2 EPS by 174c

GeneDx Holdings Corp. (NASDAQ: WGS) reported Q2 EPS of ($1.84), $1.74 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $48.71 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• RH (RH) Tops Q1 EPS by 12c